Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand-Reference-Cited by-同舟云学术

Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand

Published:2016-04-25 Issue:7 Volume:36 Page:557-566
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Bamrungsawad Naruemon,Upakdee Nilawan,Pratoomsoot Chayanin,Sruamsiri Rosarin,Dilokthornsakul Piyameth,Dechanont Supinya,Wu David Bin-Chia,Dejthevaporn Charungthai,Chaiyakunapruk Nathorn

Funder

Subcommittee for Development of the Thailand National List of Essential Medicine (NLEM), Thailand

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40261-016-0401-3.pdf

Reference40 articles.

1. Laughlin RS, Dyck PJ, Melton LJ III, et al. Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurology. 2009;73(1):39–45.

2. McLeod JG, Pollard JD, Macaskill P, et al. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol. 1999;46:910–3.

3. Lunn M, Manji H, Choudhary P, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry. 1999;66:677–80.